retinol has been researched along with Cholangiocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, L; Hu, W; Ning, S; Xue, Y; Yu, S | 1 |
| Lai, KP; Li, Y; Liang, X; Su, M; Yang, L; Zhou, R | 1 |
2 other study(ies) available for retinol and Cholangiocarcinoma
| Article | Year |
|---|---|
Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
Topics: Arachidonic Acid; Arylamine N-Acetyltransferase; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cholesterol; Cytochrome P-450 CYP2C9; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glucuronosyltransferase; Humans; Liver Neoplasms; Multigene Family; Prognosis; Retinoic Acid 4-Hydroxylase; Vitamin A | 2022 |
Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Carcinoma, Hepatocellular; Cholangiocarcinoma; Computational Biology; COVID-19; COVID-19 Drug Treatment; Female; Humans; Immunity; Inflammation; Liver Neoplasms; Male; Molecular Docking Simulation; Proportional Hazards Models; SARS-CoV-2; Signal Transduction; Vitamin A | 2021 |